DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20170328

Association between serum sodium levels and selective serotonin reuptake inhibitors in patients with depression

Rajiv S., Meena K. Nandimath

Abstract


Background: Hyponatremia is known to occur in patients on antidepressants. It is prevalent in approximately 2.5% of general hospital inpatient population, but can approach 11% among elderly patients. Relying only on symptoms for detecting hyponatremia may lead to under-diagnosing of hyponatremia; therefore, routine and frequent testing for serum sodium level is recommended, especially for older patients. This study is done to analyse the association between serum sodium levels and SSRIs in patients with depression.

Methods: A Prospective, Interventional study in the in-patient and out-patient department of Psychiatry Department was conducted for 3 months (August 2105 to October 2015). A total of 100 patients, aged over 18 years, diagnosed of depression, on SSRIs were analysed. Changes in serum sodium levels were observed at baseline and Week 4 of starting SSRI.

Results: A total of 100 patients were analyzed. 8 patients had serum sodium ≤130mmol-1, out of which 5 were females (62.5%) and 3 were males (37.5%). Prevalence of hyponatremia was more pronounced in patients aged >60 years (100%), on Fluoxetine or Sertraline. Patients between15 to 45 years of age did not experience any clinically significant hyponatremia at the fourth week after the therapy.

Conclusions: Our study indicates that users of SSRIs in elderly age group have a higher risk of developing hyponatremia. Clinicians evaluating elderly patients taking SSRIs are encouraged to monitor serum sodium if the patient presents with vague, nonspecific symptoms commonly associated with older age or depression to rule-out SIADH.


Keywords


Depression, Hyponatremia, SSRIs

Full Text:

PDF

References


Wright SK, Schroeter S. Hyponatremia as a complication of selective serotonin reuptake inhibitors. J Am Acad Nurse Pract. 2008;20:47-51.

Egger C, Muehlbacher M, Nickel M, Geretsegger C, Stuppaeck C. A review on hyponatremia associated with SSRIs, reboxetine and venlafaxine. Int J Psychiatry ClinPract. 2006;10:17-26.

Kirby D, Ames D. Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients. Int J Geriatr Psychiatry. 2001;16:484-93.

Kirby D, Harrigan S, Ames D. Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: A retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry. 2002;17:231-7.

Bogunovic O, Sotelo J, Madhusoodanan S. Hyponatremia secondary to antidepressants. Psychiatric Annals. 2003;33:333-9.

David B. Mount fluids and electrolyte disturbances. In: Fauci L, editor. Harrison's principles of internal medicine. New York: McGraw-Hill; 2012:344-351.

Rosner MH. Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors. Am J Med Sci. 2004;327:109-11.

Kirby D, Harrigan S, Ames D. Hyponatremia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and venlafaxine: a retrospective-controlled study in an inpatient unit. Int J Geriatr Psychiatry. 2002;17:231-7.

Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R. Incidence and risk factors For hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol. 1999;47:211-7.

Fabian T, Amico J, Kroboth P. Paroxetine-induced hyponatremia inolder adults: a 12-week prospective study. Arch Intern Med. 2004;164:327-32.

Inaguma D, Kitagawa W, Hayashi H, Kanoh T, Kurata K, Kumon S. Three cases of severe hyponatremia under taking selective serotonin reuptake inhibitor (SSRI). Nippon Jinzo Gakkai Shi. 2000;42:644-8.

Schouten WE, Sepers JM. Hyponatraemia associated with the use of a selective serotonin-reuptake inhibitor in an older patient (letter). Age Ageing. 2001;30:94.

Flores G, Perez-Patrigeon S, Cobos-Ayala C, Vergara J. Severe symptomatic hyponatremia during citalopram therapy. A case report. BMC Nephrol. 2004;5:2.

Arinzon ZH, Lehman YA, Fidelman ZG, Krasnyansky II. Delayed recurrent SIADH associated with SSRIs. Ann Pharmacother. 2002;36:1175-7.

Guay D. Hyponatremia associated with selective serotonin reuptake inhibitors: clinical review. Consult Pharmacist. 2000;15:160-77.

Stedman CA, Begg EJ, Kennedy MA, Roberts R, Wilkinson TJ. Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatremia. Hum Psychopharmacol. 2002;17:187-90.

Miller M, Hecker MS, Friedlander D, Carter JM. Apparent idiopathic hyponatremia in an ambulatory geriatric population. J Am Geriatr Soc. 1996;44:404-8.

Levinsky NG. Fluids and electrolytes. In: Isselbacher K, Braunwald E, editors. Harrison's Principles of Internal Medicine. New York: McGraw-Hill; 1994:242-253.

Bouman WP, Pinner G, Johnson H. Incidence of selective serotonin reuptake inhibitor (SSRI) induced hyponatraemia due to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion in the elderly. Int J Geriatr Psychiatry. 1998;13:12-15.

Sharma H, Pompei P. Antidepressant-induced hyponatraemia in the aged. Avoidance and management strategies. Drugs Aging. 1996;8:430-5.

Liu BA, Mittmann N, Knowles SR, Shear NH. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. Can Med Assoc J. 1996;155:519-27.

Kirchner V, Silver LE, Kelly CA. Selective serotonin reuptake inhibitors and hyponatraemia: review and proposed mechanisms in the elderly. J Psychopharmacol. 1998;12:396-400.

Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R. Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol. 1999;47:211-17.

Kraft M, Btaiche I, Sacks G, Kudsk K. Treatment of electrolyte disordersin adult patients in the intensive care unit. Am J Health Syst Pharm. 2005;62:1663-82.

Palm C, Pistrosch F, Herbig K, Gross P. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia. Am J Med. 2006;119(1):S87-92.

Palmer BF, Gates JR, Lader M. Causes and management of hyponatremia. Ann Pharmacother. 2003;37:1694-702.